Aehr Test Systems (AEHR) Stock Analysis

Aehr Test Systems’ principal competitive advantage lies in its proprietary wafer-level burn-in (WLBI) technology, particularly the FOX-XP platform, which enables simultaneous testing of up to 18 wafers. This parallelism delivers a cost-per-wafer and floor space advantage that competitors such as Advantest and Teradyne do not match; typical rival systems test one wafer at a time and cost 60–100% more per wafer of capacity. Aehr’s patented WaferPak contactors further lock in customers by creating recurring, high-margin consumable sales.

Aehr’s early and deep focus on silicon carbide (SiC) and, more recently, high-power AI processors, has established it as the de facto standard for reliability testing in these segments. In fiscal 2025, SiC accounted for less than 40% of revenue (down from over 90% in 2024), while AI processor testing rose to over 35%, reflecting successful diversification and reduced customer concentration risk.

Customer switching costs are high due to process integration and qualification requirements. Aehr’s installed base and long-term relationships with leading SiC and AI chipmakers (e.g., Onsemi, Infineon, major hyperscalers) reinforce its position. While larger rivals have broader portfolios, Aehr’s specialized focus, IP portfolio (50+ patents), and razor-and-blade model underpin a defensible niche. Key risks include customer concentration and the potential for technological leapfrogging by larger competitors.